« Return to News | Technology Solutions

Lehigh Valley Health Network selects StudyManager's Reveal software

Monday, November 28, 2011 01:48 PM
Lehigh Valley Health Network has selected StudyManager’s Reveal software to manage its clinical trials.
 
As a health network that includes three hospital facilities, nine health centers and numerous primary and specialty care physician practices located throughout the state of Pennsylvania, Lehigh Valley Health Network sought a solution to centralize activity across multiple facilities and departments. Billing and protocol compliance, financial accountability, patient tracking, and high-level reporting for management oversight were all important criteria in selecting a CTMS system. Following an in-depth review process, Lehigh Valley selected StudyManager Reveal.
 
“We sought a CTMS that would centralize and organize our research operations to replace numerous manual and fragmented methods of capturing and recording data across our many research departments,” said Eric Mueller, director of research administration, Lehigh Valley Health Network. “After evaluating several CTMS systems, we felt that StudyManager Reveal provided us the standardization needed, as well as the reporting capabilities to meet our compliance, study and patient tracking, and financial requirements.”
Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.